BIT 3.33% 3.1¢ biotron limited

great result from biotron, page-10

  1. 13,013 Posts.
    lightbulb Created with Sketch. 99
    Hi sulu. Patience is what it's all about in biotechs.

    One further point I forgot to mention is that while this trial has been all about HCV, the positive results augur well for other viral conditions of interest namely HIV, influenza dengue fever etc etc.

    Remember we are dealing with a totally new viral inhibition concept here that is in the nature of a platform technology.
 
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.